United Therapeutics Corporation

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 593.54 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 25.46B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of tre...